HealthEquity, Inc. $HQY Shares Acquired by One Capital Management LLC

One Capital Management LLC lifted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 57.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,695 shares of the company’s stock after purchasing an additional 8,642 shares during the period. One Capital Management LLC’s holdings in HealthEquity were worth $2,171,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HQY. Sivia Capital Partners LLC acquired a new stake in shares of HealthEquity in the second quarter valued at about $306,000. Arrowstreet Capital Limited Partnership acquired a new stake in shares of HealthEquity in the second quarter valued at about $4,747,000. Marshall Wace LLP acquired a new stake in shares of HealthEquity in the second quarter valued at about $5,483,000. Amundi lifted its stake in shares of HealthEquity by 9.3% in the second quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after purchasing an additional 2,574 shares during the period. Finally, Jump Financial LLC acquired a new stake in shares of HealthEquity in the second quarter valued at about $449,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on HQY. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Barclays reduced their price objective on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research note on Wednesday, February 18th. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a research note on Monday. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research note on Thursday, March 19th. Finally, BMO Capital Markets upgraded shares of HealthEquity from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $85.00 to $105.00 in a research note on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and an average target price of $111.53.

Insiders Place Their Bets

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the sale, the executive vice president directly owned 59,113 shares of the company’s stock, valued at $5,615,735. This trade represents a 5.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the firm’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director directly owned 19,733 shares in the company, valued at $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 13,081 shares of company stock valued at $1,193,000 in the last ninety days. Insiders own 1.60% of the company’s stock.

HealthEquity Price Performance

HealthEquity stock opened at $88.34 on Wednesday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $116.65. The stock has a market capitalization of $7.39 billion, a P/E ratio of 33.09, a P/E/G ratio of 1.55 and a beta of 0.21. The firm’s 50-day moving average is $83.63 and its two-hundred day moving average is $86.61. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities analysts predict that HealthEquity, Inc. will post 3.84 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.